CODEXIS INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
CDXS$1.00-9.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In Thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Operating activities: | |||
| Net loss | $(76,240) | $(33,592) | $(21,279) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation | 5,518 | 5,402 | 3,113 |
| Amortization expense - right-of-use assets - operating and finance leases | 4,405 | 4,849 | 2,834 |
| Stock-based compensation | 9,971 | 14,531 | 11,593 |
| Provision (recovery) for credit losses | (65) | 4 | 342 |
| Equity securities earned from research and development activities ($0, ($1,245), and ($1,955) from a related party) | (213) | (1,245) | (1,955) |
| Unrealized gain on non-marketable securities ($0, ($208), and ($983) from a related party) | — | (208) | (1,272) |
| Asset impairment and other charges | 9,984 | — | — |
| Impairment of investment in non-marketable securities | 12,215 | — | — |
| Other non-cash items | 4 | (29) | (19) |
| Changes in operating assets and liabilities: | |||
| Financial assets | 20,247 | (3,225) | (9,156) |
| Inventories | (656) | (869) | (196) |
| Prepaid expenses and other assets | (865) | 181 | (2,268) |
| Accounts payable | 2,287 | 207 | 268 |
| Accrued compensation and other accrued liabilities | (14,041) | 5,983 | 6,575 |
| Other long-term liabilities | (5,341) | (5,223) | (4,147) |
| Deferred revenue ($0, $0, $245 to a related party) | (19,848) | 24,518 | 1,300 |
| Net cash provided by (used in) operating activities | (52,638) | 11,284 | (14,267) |
| Investing activities: | |||
| Purchase of property and equipment | (4,418) | (8,307) | (13,828) |
| Proceeds from sale of property and equipment | 751 | 29 | 36 |
| Investment in non-marketable securities ($0, $0, and ($7,630) in a related party) | (1,191) | (5,300) | (7,630) |
| Net cash used in investing activities | (4,858) | (13,578) | (21,422) |
| Financing activities: | |||
| Proceeds from exercises of stock options | 422 | 955 | 5,180 |
| Proceeds from issuance of common stock in connection with public offering | 8,652 | — | — |
| Costs incurred in connection with issuance of common stock at public offering | (503) | (42) | (207) |
| Taxes paid related to net share settlement of equity awards | (404) | (1,488) | (1,206) |
| Net cash provided by (used in) financing activities | 8,167 | (575) | 3,767 |
| Net decrease in cash, cash equivalents and restricted cash | (49,329) | (2,869) | (31,922) |
| Cash, cash equivalents and restricted cash at the beginning of the year | 116,026 | 118,895 | 150,817 |
| Cash, cash equivalents and restricted cash at the end of the year | $66,697 | $116,026 | $118,895 |
| Supplemental disclosure of cash flow information: | |||
| Interest paid | $44 | $34 | $14 |
| Income taxes | $194 | $100 | $102 |
| Supplemental non-cash investing and financing activities: | |||
| Capital expenditures incurred but not yet paid | $1,068 | $897 | $2,533 |
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown above (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash and cash equivalents | $65,116 | $113,984 | $116,797 |
| Restricted cash, current and non-current | 1,581 | 2,042 | 2,098 |
| Total cash, cash equivalents and restricted cash at the end of the period | $66,697 | $116,026 | $118,895 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.